{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:17:58Z","timestamp":1785435478059,"version":"3.56.0"},"reference-count":14,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"unspecified","delay-in-days":280,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Law. Med. Ethics"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Narratives and frames have shaped the overdose crisis since its early stages. Efforts to control knowledge about the role of opioids in chronic pain have influenced clinical guidelines and prescribing behaviour. Dominant narratives shape policy by influencing how problems are defined, and which solutions are considered appropriate. A more nuanced understanding of how framing shapes interactions among stakeholders, including patients, clinicians, advocacy groups, industry, educators, and regulators, can clarify these dynamics. Engaging multiple perspectives, rather than relying on a single dominant narrative, offers a more effective path for addressing complex public health emergencies such as the overdose crisis.<\/jats:p>","DOI":"10.1017\/jme.2025.10184","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T07:05:53Z","timestamp":1759907153000},"page":"561-562","source":"Crossref","is-referenced-by-count":0,"title":["Framing, Narratives, and the Overdose Crisis"],"prefix":"10.1017","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7323-0435","authenticated-orcid":false,"given":"Itai","family":"Bavli","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rmrcq20","id-type":"ROR","asserted-by":"publisher"}],"name":"The University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"S1073110525101848_r2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31918-9"},{"key":"S1073110525101848_r5","doi-asserted-by":"publisher","DOI":"10.20529\/IJME.2024.006"},{"key":"S1073110525101848_r6","doi-asserted-by":"publisher","DOI":"10.28938\/9780995527775"},{"key":"S1073110525101848_r1","first-page":"xxx","article-title":"Constructing Opioid Legitimacy: The Canadian Pain Task Force\u2019s Framing of the Overdose Crisis","volume":"53","author":"Klein","year":"2025","journal-title":"Journal of Law, Medicine and Ethics"},{"key":"S1073110525101848_r3","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2007.131714"},{"key":"S1073110525101848_r8","volume-title":"Pain Killer: An Empire of Deceit and the Origin of America\u2019s Opioid Epidemic","author":"Meier","year":"2018"},{"key":"S1073110525101848_r12","first-page":"1","article-title":"National patient groups in Canada and their disclosure of relationships with pharmaceutical companies: A cross-sectional study,\u201d BMJ","volume":"12","author":"Lexchin","year":"2022","journal-title":"Open"},{"key":"S1073110525101848_r7","unstructured":"7. Prescription Drugs: OxyContin Abuse and Diversion and Efforts to Address the Problem (United States General Accounting Office, 2003), GAO-04-011, https:\/\/www.gao.gov\/assets\/gao-04-110.pdf."},{"key":"S1073110525101848_r13","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2013-101343"},{"key":"S1073110525101848_r4","volume-title":"Empire of Pain: The Secret History of the Sackler Dynasty","author":"Keefe","year":"2021"},{"key":"S1073110525101848_r10","doi-asserted-by":"publisher","DOI":"10.1177\/17407745221108436"},{"key":"S1073110525101848_r11","doi-asserted-by":"publisher","DOI":"10.1017\/jme.2023.67"},{"key":"S1073110525101848_r9","doi-asserted-by":"publisher","DOI":"10.1111\/add.14929"},{"key":"S1073110525101848_r14","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170628"}],"container-title":["Journal of Law, Medicine &amp; Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1073110525101848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:23:01Z","timestamp":1770297781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1073110525101848\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"alternative-id":["S1073110525101848"],"URL":"https:\/\/doi.org\/10.1017\/jme.2025.10184","relation":{},"ISSN":["1073-1105","1748-720X"],"issn-type":[{"value":"1073-1105","type":"print"},{"value":"1748-720X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}